Twist Bioscience Corporation - Common Stock (NQ:TWST)

166.97 -38.03 (-18.55%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Twist Bioscience to Present at Baird Global Healthcare Conference 2024

August 27, 2024

From Twist Bioscience Corporation

Via Business Wire

How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

August 14, 2024

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:EXAI),(NASDAQ:TWST),(NYSE:IQV) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb

August 08, 2024

From Twist Bioscience Corporation

Via Business Wire

Evaluating Twist Bioscience: Insights From 5 Financial Analysts ↗

August 05, 2024

Via Benzinga

How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

August 14, 2024

From FN Media Group LLC

Via GlobeNewswire

3 Healthcare AI Stocks Positioned for Potential Breakthroughs ↗

August 07, 2024

The Japanese central bank’s decision creates a prime opportunity. Take advantage of it with these three healthcare AI stocks.

Via InvestorPlace

Topics Artificial Intelligence Economy

Key Takeaways From Twist Bioscience Analyst Ratings ↗

June 28, 2024

Via Benzinga

Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts ↗

June 05, 2024

Via Benzinga

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

August 06, 2024

From Twist Bioscience Corporation

Via Business Wire

Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday ↗

August 05, 2024

Via Benzinga

The 3 Best Med Tech Stocks to Buy Now ↗

August 05, 2024

Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now.

Via InvestorPlace

Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis

August 05, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Beats Q3 Earnings Forecast, Plans To Achieve 50% Gross Margin By Fiscal Year 2025 ↗

August 02, 2024

Twist Bioscience reported a Q3 adjusted EPS loss of $(0.70), surpassing the $(0.77) consensus. With a net loss of $85.6 million and sales at $81.5 million, Twist Bioscience saw a 27.8% year-over-year...

Via Benzinga

Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results

August 02, 2024

From Twist Bioscience Corporation

Via Business Wire

Biotech Bull Market Is Intact But SMIDs Are Too Volatile ↗

July 22, 2024

It was another wild week for the market as it had to contend with a lot of news.

Via Talk Markets

Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries

July 18, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024

July 11, 2024

From Twist Bioscience Corporation

Via Business Wire

Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates ↗

July 11, 2024

In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance.

Via Benzinga

Topics ETFs

Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies

July 10, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A

July 09, 2024

From Twist Bioscience Corporation

Via Business Wire

Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today ↗

July 02, 2024

Via Benzinga

Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? ↗

June 09, 2024

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts.

Via Benzinga

Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor

June 06, 2024

From Twist Bioscience Corporation

Via Business Wire

Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday ↗

June 05, 2024

Via Benzinga

This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

June 05, 2024

Via Benzinga

Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety

June 04, 2024

From Twist Bioscience Corporation

Via Business Wire

Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗

June 03, 2024

Via Benzinga

Twist Bioscience to Present at Upcoming Investor Conferences

May 23, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications

May 13, 2024

From Twist Bioscience Corporation

Via Business Wire

Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗

May 10, 2024

Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.